Featured Post

2 mins read

FDA Approves Rebyota: The First Fecal Transplant Therapy

On November 30, 2022, Rebyota, the FDA approved first fecal transplant therapy for the prevention of recurrence of Clostridioides difficile […]

ikrisuser
December 2, 2022
2 mins read

FDA Approves Hemgenix- World’s First Gene Therapy for Adults with Hemophilia B

On November 22, 2022, the U.S. FDA approved Hemgenix (Etranacogene Dezaparvovec; CSL Behring LLC.) for treating adults with Hemophilia B […]

ikrisuser
November 24, 2022
2 mins read

U.S FDA Approves a New Intramuscular Dosing Regimen for Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn)

On November 18, 2022, the U.S. FDA approved a new Monday/Wednesday/Friday (MWF) intramuscular (IM) dosing schedule for asparaginase erwinia chrysanthemi […]

ikrisuser
November 22, 2022
2 mins read

Indian pharmaceutical market : Boosting healthcare in South Africa

India is one of the largest pharmaceutical manufacturers and exporters globally. According to India brand equity foundation. India is the […]

ikrisuser
November 21, 2022
2 mins read

Imfinzi and Imjudo with Chemotherapy Approved in the US for Patients with Metastatic NSCLC

On November 10, 2022, the FDA approved tremelimumab (Imjudo, AstraZeneca) plus durvalumab (Imfinzi, AstraZeneca) and platinum-based chemotherapy for adult patients […]

ikrisuser
November 21, 2022
2 mins read

Alembic Pharmaceuticals Gets Final USFDA Nod For Glycopyrrolate Injection

On November 01, 2022, Alembic Pharmaceuticals Limited (Alembic) said it has received final approval from the US health regulator (US […]

ikrisuser
November 21, 2022
2 mins read

Low-Dose Immunotherapy (LDI) May be Revolutionary

Low-dose immunotherapy (LDI), a modern modality to treat cancer, could be revolutionary if it demonstrates competent outcomes. Specialists have started […]

ikrisuser
November 13, 2022
3 mins read

Acute Intermittent Porphyria: Comprehensive information

Porphyrias are metabolic disorders caused by altered activities of enzymes within the heme biosynthetic pathway. Porphyrias can cause neurovisceral manifestations […]

ikrisuser
November 2, 2022
2 mins read

US FDA Approves Tecvayli® (Teclistamab-cqyv) for Relapsed/Refractory Multiple Myeloma (RRMM)

On October 25, 2022, the US FDA granted accelerated approval to Tecvayli® (teclistamab-cqyv, Janssen Biotech, Inc.) for adult patients with […]

ikrisuser
October 28, 2022
2 mins read

US FDA Approves Boostrix for Whooping Cough (Pertussis) Prevention in Infants Aged Younger Than Two Months

On October 07, 2022, the U.S. FDA approved GlaxoSmithKline’s Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed […]

ikrisuser
October 11, 2022
We Offer You

Partnership

We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.

Learn More